Rayego-Mateos, S.; Marquez-Exposito, L.; Basantes, P.; Tejedor-Santamaria, L.; Sanz, A.B.; Nguyen, T.Q.; Goldschmeding, R.; Ortiz, A.; Ruiz-Ortega, M.
CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation. Antioxidants 2023, 12, 1541.
https://doi.org/10.3390/antiox12081541
AMA Style
Rayego-Mateos S, Marquez-Exposito L, Basantes P, Tejedor-Santamaria L, Sanz AB, Nguyen TQ, Goldschmeding R, Ortiz A, Ruiz-Ortega M.
CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation. Antioxidants. 2023; 12(8):1541.
https://doi.org/10.3390/antiox12081541
Chicago/Turabian Style
Rayego-Mateos, Sandra, Laura Marquez-Exposito, Pamela Basantes, Lucia Tejedor-Santamaria, Ana B. Sanz, Tri Q. Nguyen, Roel Goldschmeding, Alberto Ortiz, and Marta Ruiz-Ortega.
2023. "CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation" Antioxidants 12, no. 8: 1541.
https://doi.org/10.3390/antiox12081541
APA Style
Rayego-Mateos, S., Marquez-Exposito, L., Basantes, P., Tejedor-Santamaria, L., Sanz, A. B., Nguyen, T. Q., Goldschmeding, R., Ortiz, A., & Ruiz-Ortega, M.
(2023). CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation. Antioxidants, 12(8), 1541.
https://doi.org/10.3390/antiox12081541